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The hemodynamic effect of stenosis of an inter-
nal carotid artery (ICA) depends on the severity of
the stenosis and on the potential of the collateral cir-
culation. When the ICA stenosis results in a
decreased cerebral perfusion pressure (CPP), cere-
bral blood flow (CBF) can be kept constant with a
decrease in cerebrovascular resistance (CVR). This
mechanism is called cerebral autoregulation and is
mediated by dilatation of arteriolar cerebral vessels.
If the collateral blood flow is inadequate, the CPP
may decrease so much that the cerebral autoregula-
tion mechanism fails. In this condition, cerebral
arterioles are maximally or almost maximally dilated
and are resistant to any further vasodilator stimulus,
such as hypercapnia. The change in CBF in response
to hypercapnia, which is experimentally induced by
inhalation of a gas mixture with a raised carbon
dioxide (CO2) content, is called CO2 reactivity. This
CO2 effect is mediated by vasodilatation of the cere-
bral arterioles, whereas the proximal cerebral arteries
are not affected.1 Because the diameter of the prox-
imal arteries remains constant, changes in blood
flow velocity (BFV) in these vessels reflect the
changes in blood flow as a result of vasodilatation of
the cerebral arterioles. With transcranial Doppler
(TCD) sonography, the BFV in the proximal parts of
cerebral arteries can be measured, and the CO2 reac-
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tivity of the cerebral vessels is expressed as the rela-
tive change in BFV during provocation with CO2
inhalation.2
When the cerebral autoregulation mechanism
fails, CBF also fails. At first, the rate of oxygen
extraction from the blood increases to maintain aer-
obic glycolysis, but a further decrease in CPP may
result in anaerobic metabolism and finally ischemic
cerebral damage (low-flow infarction). The extent of
anaerobic metabolism can be determined by mea-
suring N-acetyl aspartate (NAA), choline, and lac-
tate levels with 1H magnetic resonance spectroscopy
(MRS). It has been shown that the extent of anaer-
obic metabolism (increased lactate and decreased
NAA/choline ratio) corresponds with the severity of
carotid lesions3 and is associated with a low blood
flow in the middle cerebral artery (MCA).4
The aim of the present study was to investigate
whether a decreased CO2 reactivity is associated
with a disordered cerebral metabolism, measured
with MRS, in patients with unilateral or bilateral
stenosis of the ICA. This finding would support the
use of the CO2 reactivity test to identify patients at
risk for disordered cerebral hemodynamics.
SUBJECTS AND METHODS
Patients. Sixty-six patients with an ICA stenosis
of at least 70% who were scheduled for carotid
endarterectomy (CEA) and who had undergone
both a TCD CO2 reactivity test and a MRS exami-
nation during the period from June 1995 to July
1996 were included in this study. When a bilateral
ICA stenosis of more than 70% was found (n = 14),
the symptomatic side was scheduled for surgery (n =
8), or, if both sides were asymptomatic (n = 5) or
symptomatic (n = 1), the most severely stenosed side
was operated on. The extent of ICA stenosis was
determined by means of angiography (70% stenosis
according to North American Symptomatic Carotid
Endarterectomy Trial criteria). The hemisphere 
of the carotid artery scheduled for CEA was termed
the CEA side, and the other hemisphere was termed
the contralateral side. The Ethics Committee of the
University Hospital Utrecht approved the study, and
the patients gave their informed consent.
The mean age of the patients was 65 ± 10 years,
and 65% of the patients were men (n = 43). The
contralateral ICA was occluded in 20% of the sub-
jects (n = 13) and was stenosed by at least 70% in
21% of the subjects (n = 14) and by less than 70% in
59% of the subjects (10 patients with 30% to 69%
stenosis, and 29 patients with less than 30% stenosis
or no stenosis). Three groups were formed on the
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basis of these differences in the extent of stenosis of
the contralateral ICA.
In the year before inclusion, 43 patients (65%)
had symptoms only of the CEA-side hemisphere. Of
these patients, 14 had a minor stroke, 20 experi-
enced one or more transient ischemic attacks (TIAs),
and nine experienced ocular symptoms (ie, seven
patients with transient monocular blindness and two
patients with impaired vision caused by chronic reti-
nal ischemia). In eight patients, signs and symptoms
were restricted to the contralateral side (two patients
with a minor stroke and six patients with TIAs). All
these eight patients had an ICA occlusion at the
contralateral side. Five patients had symptoms on
both sides (three patients with bilateral ocular symp-
toms and two patients with bilateral transient cere-
bral ischemic symptoms). The three patients with
bilateral ocular symptoms had normal vertebrobasi-
lar angiogram findings, and the symptoms could not
be attributed to vertebrobasilar insufficiency. Ten
patients (15%) were asymptomatic. The distribution
of unilateral or bilateral clinical symptoms between
the groups based on the contralateral ICA stenosis is
shown in Table I.
Transcranial Doppler with CO2 reactivity test.
The TCD examination was performed with a DWL
multidop-X device (Sipplingen, Germany) and two 2-
MHz pulsed Doppler probes. The method used has
been described previously.5 First, a standard TCD
examination was performed to locate the vessels.
Then, the CO2 reactivity was measured simultaneous-
ly in both MCAs, the main cerebral arteries supplied
by the ICA. The TCD probes were fitted in a light
metal frame, which was firmly fixed to the head with
two earpieces and an adjustable nose saddle (manu-
factured by DWL). The BFV in the MCA was record-
ed while the patients were lying down with their eyes
closed. If an intracranial vessel could not be insonat-
ed, this was considered as a missing value and was not
included in the statistical analysis. Hypercapnia was
induced with inhalation of a gas mixture with 5% CO2
and 95% oxygen (carbogene) through a mouthpiece
connected to a respiratory balloon. A nose clip
ensured proper inhalation of carbogene. The CO2
content of the breathing gas was continuously moni-
tored with an infrared gas analyzer (Mijnhardt). After
a 2-minute baseline period, patients inhaled carbo-
gene for 2 minutes. A spectral TCD recording of 5
seconds duration was made after 1 minute during the
baseline period and after 1.5 minutes of carbogene
inhalation. At the same time, blood pressure (BP) was
measured with an automatic device (Omega 1000;
Invivo Research Laboratories, Scott’s Valley, Calif) to
exclude the possibility that BFV changes were caused
by BP changes. The CO2 reactivity after 1.5 minutes
of inhalation of carbogene was measured as the rela-
tive change in BFV from the mean baseline BFV. The
mean of the maximal BFV during the spectral TCD
recordings was used in this calculation.
Control CO2 reactivity was measured in 30 sub-
jects without cerebrovascular disorders (mean age,
59 ± 10 years; 83% men) who were scheduled for
implantation of an internal cardioverter defibrillator.
In both hemispheres, the median CO2 reactivity was
52%, and the fifth percentile was 30%. Based on
these data, we considered a CO2 reactivity below
30% to be abnormal.
Magnetic resonance imaging and MRS. MRI
and MRS studies were performed on a 1.5T whole
body system (ACS/NT15 model; Philips Medical
Systems, Best, The Netherlands). For MRI, the fol-
lowing pulse sequences were used: a sagittal T1-
weighted spin-echo sequence (repetition time, 545
ms; echo time, 15 ms; one signal acquired; 4-mm sec-
tion thickness; 0.6-mm intersection gap; 225-mm
FOV; 256 · 256 matrix), followed by a transaxial T2-
weighted spin-echo sequence (repetition time, 2 sec-
onds; echo time, 20 and 100 ms; two signals acquired;
7-mm section thickness; 1.5-mm intersection gap;
225-mm field of view; 256 · 256 matrix).
As in a previous study, 1H MRS was performed
with a single volume technique, using T2-weighted
transaxial MRI images. In each subject, two single
volumes of interest (VOI) were selected in the cen-
trum semiovale, one on the CEA side and one on the
contralateral side. The anterior-posterior and left-
right dimensions of the VOI were chosen so that
regions containing subcutaneous lipid were excluded
and were typically 70 mm and 35 mm in anterior-
posterior and left-right directions. In all subjects, the
caudal-cranial dimension of the VOI was 15 mm. All
VOI were positioned at least 2 cm away from
gray/white matter hyperintensities. In each MR
examination, the dimensions of the selected VOI
were the same for both hemispheres. Thus, all VOI
contained mainly white matter. After selection of a
VOI, the 90-degree pulse length was determined. To
minimize eddy currents and to maximize the water
echo signal, localized spectroscopy was first per-
formed without water suppression for adjustments of
the gradients (gradient tuning). This was followed by
localized automatic shimming of the VOI, which
resulted in a water resonance line-width of 6 Hz (full
width at half maximum) or less. Water suppression
was performed with selective excitation (60-Hz
bandwidth), followed by a spoiler gradient. A double
spin-echo point-resolved spectroscopy (PRESS)
sequence was used for VOI localization. Each mea-
surement was performed with a repetition time of 2
seconds and an echo time of 136 ms, and 2048 time
domain data points, 4000-Hz spectral width, and 64
or 128 signals were acquired. After zerofilling to
4096 data points, Gaussian multiplication of 5 Hz,
exponential multiplication of 4 Hz (line broadening),
Fourier transformation and linear baseline correc-
tion, total choline, NAA (referenced at 2.01 ppm),
and lactate peaks were identified by their chemical
shifts. Because this MRS method does not enable us
to calculate absolute metabolic concentrations, meta-
bolic data are expressed as the ratio between peak
intensities (NAA/choline ratio). To distinguish lac-
tate resonances from lipid resonances at an echo time
of 136 ms, lactate was defined as an inverted reso-
nance at 1.33 ppm, with a signal-to-noise ratio larg-
er than 2 and a clearly identifiable 7-Hz J-coupling.
Lactate was documented as either absent or present.
In 19 healthy volunteers, (mean age, 58 ± 11
years; 74% men), the mean NAA/choline ratio was
1.93 ± 0.17. Therefore, we considered a ratio of less
than 1.59 to be decreased (ie, < mean – 2SD).
Statistical analysis. For continuous variables,
the t test for independent samples was used for the
analysis of differences between two groups. For dif-
ferences among more than two groups, analysis of
variance (ANOVA) was used for the first overall
analysis. When the ANOVA procedure showed a sig-
nificant difference, the least significance difference
(LSD) method was used for further analysis of dif-
ferences. All values are given as means ± SD, unless
otherwise indicated. The relation between two con-
tinuous variables is expressed as the Pearson correla-
tion coefficient. Data for lactate were treated as ordi-
nal variables, because in many cases no lactate peak
could be detected in the MRS spectra. For noncon-
tinuous variables, differences between groups in
cross-tabs were assessed with Pearson’s chi-square
test or Fisher’s exact test. A P value less than .05 was
considered statistically significant.
RESULTS
It was not possible to perform a CO2 reactivity
test in eight patients at the CEA side (12%) and in
10 patients at the contralateral side (15%) because of
the inability to insonate the MCAs through the tem-
poral bone. The mean CO2 reactivity on the CEA
side was 40% ± 19%, and on the contralateral side, it
was 41% ± 22%. For those 56 patients in whom a
CO2 reactivity test at one or both sides could be per-
formed, the mean BP increased 6% from 113 mm
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Hg during the baseline period to 120 mm Hg dur-
ing the carbogene inhalation (P < .001). If cerebral
autoregulation is disregarded, such a slight increase
in BP could only explain an increase in BFV of 6%
during the CO2 reactivity test. However, autoregu-
lation would normally ensure a stable CBF (and
BFV in the MCA) with such fluctuations in BP.
MRS could be performed in all patients. The results
for a 51-year-old woman with occlusion of the con-
tralateral ICA are shown in Fig 1. The CO2 reactiv-
ity on the CEA side was 31%, and on the contralat-
eral side, it was 12% (Fig 1A). After CEA, the CO2
reactivity increased to 44% on the CEA side and to
40% on the contralateral side. The rectangular box
in the MRI shown in Fig 1B indicates the dimen-
sions of the VOI chosen, and the corresponding 1H
MR spectra of both sides are shown in Fig 1C. The
NAA/choline ratio was 1.82 on the CEA side and
1.64 on the contralateral side. Lactate was present in
both hemispheres.
There was a modest but statistically significant
correlation (r = .43) between the CO2 reactivity and
the NAA/choline ratio in both hemispheres (P <
.001; Fig 2). In both hemispheres, the CO2 reactiv-
ity was significantly lower in patient groups with a
decreased NAA/choline ratio in the corresponding
hemisphere (Table II). In groups formed on the
basis of the presence of lactate, only in the corre-
sponding contralateral hemisphere was the CO2
reactivity significantly decreased, although a similar
trend was found at the CEA side (Table III). In nine
patients, a bilateral decreased CO2 reactivity was
found. In this subgroup, the presence of a decreased
NAA/choline ratio or lactate was not significantly
different, compared with the patients with an unilat-
eral decreased CO2 reactivity at the CEA side.
Fig 1A. Transcranial Doppler registration of the blood
flow velocity in both middle cerebral arteries during the
CO2 reactivity test. The 51-year-old female subject has
more than 70% stenosis of the left internal carotid artery
(carotid endarterectomy side) and occlusion of the right
internal carotid artery (contralateral side). The CO2 reac-
tivity on the carotid endarterectomy side was 31% and on
the contralateral side 12% (ET CO2, end-tidal CO2).
Fig 1C. 1H magnetic resonance spectra from the volumes
of interest selected in the left and right hemispheres from
the patient shown in Figs 1A and 1B. The chemical-shift
axis in parts per million (ppm) is positioned below each
spectrum (Cho, choline; Cr, creatine; NAA, N-acetyl aspar-
tate; Lac, lactate). The NAA/choline ratio on the carotid
endarterectomy side was 1.82, and on the contralateral
side, it was 1.64. Lactate was present in both hemispheres.
Fig 1B. Transversal T2-weighted magnetic resonance
image showing the centrum semiovale from the same
patient represented in Fig 1A. The white box within the
brain parenchyma indicates the volume of interest selected
for 1H magnetic resonance spectroscopy.
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The CO2 reactivity, NAA/choline ratio, and the
presence of lactate on the CEA side were not signif-
icantly different for the three groups formed on the
basis of the contralateral ICA stenosis, but were on
the contralateral side (Table IV). The CO2 reactivi-
ty and NAA/choline ratio on the contralateral side
were significantly lower in the group with an occlud-
ed ICA than in the groups of patients with a more
than 70% stenosis or less than 70% stenosis. In addi-
tion, lactate was present in 85% of the patients in the
occluded ICA group, compared with 29% and 13%
of the patients in the groups with more than 70% or
less than 70% stenosis, respectively.
The CO2 reactivity or the presence of lactate on
the CEA side was not significantly different between
groups formed on the basis of symptoms on this side
(Table V). However, the NAA/choline ratio was
lower in the groups of patients who had a minor
stroke or transient symptoms than in the group of
patients with ocular symptoms or the asymptomatic
group. If groups were formed on the basis of symp-
toms on the contralateral side (Table VI), both the
CO2 reactivity and the NAA/choline ratio on this
contralateral side were lower in the groups of patients
who had a minor stroke or transient cerebral symp-
toms than in the group of patients with ocular symp-
toms or the asymptomatic group. In addition, lactate
was present in 77% of the symptomatic patients
(either ocular symptoms, transient symptoms, or
minor stroke), which contrasts with the presence of
lactate in only 19% of the patients in the asympto-
matic group (P < .001 with Fisher’s exact test).
DISCUSSION
The hemodynamic effect of ICA obstruction is
dependent on the individual potential of the collater-
al cerebral circulation.6-8 An ipsilaterally lowered
CO2 reactivity can be found in patients with severe
stenosis of the ICA, especially when the contralateral
ICA is also obstructed.9-14 The CO2 reactivity might
be superior to the measured degree of ICA stenosis
alone as an indicator of the hemodynamic conse-
quences of ICA stenosis, because CO2 reactivity also
depends on the quality of the collateral circulation.
As illustration of the clinical significance of the CO2
reactivity, especially in patients with low-flow infarc-
tions, patients with chronic retinal ischemia or hypo-
static TIAs have a lowered CO2 reactivity.13,15-20
Also, a low or absent cerebrovascular reactivity, either
measured with CO2 or acetazolamide as vasodilator
stimulus, is a risk factor for subsequent ischemic cere-
bral complications.21-24 Finally, after CEA, the CO2
reactivity has been shown to increase on both sides,
reflecting the improvement of cerebral hemodynam-
ics.5,25-27 Similar results were found with alternative
methods to measure cerebrovascular reserve based
on changes in regional cerebral blood flow and/or
volume, such as with single-photon emission com-
puted tomography, positron emission tomography,
or MRI.28-30 Also, an association was found between
a decreased acetazolamide response and the presence
of high intensity signals on MRI, especially when
located in the centrum semiovale.31 With MRS, a
decreased NAA and choline concentration and
increased lactate concentration can be found in the
Fig 2. Relation between the CO2 reactivity and the N-acetyl
aspartate (NAA)/choline ratio on the carotid endarterectomy
side •; solid trend line) and on the contralateral side (o; dashed
trend line). Trend lines represent an assumed linear correlation
between these variables (with r = 0.43 for both lines).
Table I. The distribution of clinical symptomatol-
ogy between groups based on the degree of con-
tralateral internal carotid artery stenosis 
Degree of contralateral ICA stenosis
Clinical symptoms < 70% ‡ 70% Occlusion Total
CEA side only 33 8 2 43
Ocular 7 2 – 9
TIA 16 3 1 20
Minor stroke 10 3 1 14
Contralateral side only – – 8 8
TIA – – 6 6
Minor stroke – – 2 2
Bilateral symptoms 2 1 2 5
Bilateral ocular 1 1 1 3
Bilateral TIA 1 – 1 2
Asymptomatic 4 5 1 10
ICA, Internal carotid artery; CEA, carotid endarterectomy; TIA,
transient ischemic attack.
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area of a cerebral infarct. Similar changes, reflecting
disordered metabolism, are also found in noninfarct-
ed cerebral regions with a reduced MCA blood flow.4
A statistically significant correlation was found
between the CO2 reactivity and the NAA/choline
ratio for both hemispheres. However, the correlation
was only moderate. A possible explanation is that a
short period of compromised cerebral circulation
may result in long-term changes in NAA, choline,
and lactate concentrations. These changes can be
detected for weeks or months, even after restoration
of the cerebral circulation. In contrast, CO2 reactivi-
ty can be expected to reflect the temporary situation.
So, when formerly compromised hemodynamics
have been restored as a result of collateral pathway
development, or when the disordered metabolism
was the result of a temporary decrease in blood pres-
sure, MRS findings may still be abnormal, whereas
the CO2 reactivity may be normal.
In the present study, hemodynamics were most
compromised in patients with an ICA occlusion on the
contralateral side. On this contralateral side, both the
mean CO2 reactivity and NAA/choline ratio were
decreased to values we consider abnormal, and in 85%
of the cases, lactate was found. In the group of patients
with more than 70% stenosis and the group of patients
with maximally 70% stenosis on the contralateral side,
CO2 reactivity and the NAA/choline ratio were nor-
mal, and lactate was present in considerably fewer
patients. The presence of an ICA occlusion on the
contralateral side might be expected to influence the
variables measured on the CEA side, because collater-
al flow would be strongly directed towards the side of
the ICA occlusion, thus limiting collateral flow to the
Table II. Difference in CO2 reactivity and percentage of patients with decreased CO2 reactivity (less than
30%) between groups formed on the basis of the magnetic resonance spectroscopy N-acetyl aspartate
(NAA)/choline ratio
NAA/choline ratio on CEA side Statistics
CEA side Normal (‡ 1.59) Decreased (< 1.59) Results P value
CO2 reactivity (%) 44 ± 19 31 ± 17 t (56) = –2.6 < .05
(n = 39) (n = 19) (t test)
Decreased (< 30%)* 18% (n = 7) 53% (n = 10)
NAA/choline ratio on contralateral side Statistics
Contralateral side Normal (‡ 1.59) Decreased (<1.59) Results P value
CO2 reactivity (%) 45 ± 19 28 ± 26 t (54) = –2.5 <.05
(n = 44) (n = 12) (t test)
Decreased (<30%)* 25% (n = 11) 50% (n = 6)
*Based on control data of 30 subjects (see methods section).
CEA, Carotid endarterectomy.
Table III. Difference in CO2 reactivity and percentage of patients with decreased CO2 reactivity (less than
30%) between groups formed on the basis of the magnetic resonance spectroscopy lactate presence
Lactate on CEA side Statistics
CEA side Absent Present Results P value
CO2 reactivity (%) 43 ± 19 36 ± 19 t (56) = 1.4 NS
(n = 27) (n = 31) (t test)
Decreased (< 30%)* 19% (n = 5) 39% (n = 12)
Lactate on contralateral side Statistics
Contralateral side Absent Present Results P value
CO2 reactivity (%) 48 ± 20 27 ± 19 t (54) = 3.8 < .001
(n = 38) (n = 18) (t test)
Decreased (< 30%)* 18% (n = 7) 56% (n = 10)
*Based on control data of 30 subjects (see methods section).
CEA, Carotid endarterectomy.
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CEA side. Although in a previous study a statistically
significant decreased CO2 reactivity was found on 
the CEA side in these patients,5 in the present study,
only a trend towards a lower CO2 reactivity and
NAA/choline ratio was found for the CEA side.
However, not all patients with a contralateral ICA
occlusion show abnormal CO2 reactivity and MRS val-
ues, and abnormal values are also found in patients
Table IV. Differences between groups formed on the basis of the extent of internal carotid artery stenosis
contralateral to the carotid endarterectomy side and percentage of patients with abnormal test values
ICA stenosis on contralateral side Statistics
< 70% ‡ 70% Occlusion Results P value
CEA side
CO2 reactivity (%) 40 ± 17 (n = 33) 45 ± 27 (n = 12) 33 ± 17 (n = 13) F (2, 55) = 1.1 NS
(ANOVA)
Decreased (< 30%)† 27% (n = 9) 25% (n = 3) 39% (n = 5)
NAA/choline ratio 1.65 ± 0.23 (n = 39) 1.73 ± 0.24 (n = 14) 1.62 ± 0.15 (n = 13) F (2, 63) = 1.1 NS
(ANOVA)
Decreased (< 1.59)‡ 41% (n= 16) 29% (n= 4) 15% (n= 2)
Lactate:
Absent (n) 19 5 7 X2 = 1.0 NS
Present (n) 20 9 6 (cross-tabs)
Present (%) 51% 64% 46%
Contralateral side
CO2 reactivity (%) 50 ± 13 (n= 32) 43 ± 27 (n= 12) 18 ± 18 (n= 12) F (2, 53) = 14.4 < .001*
(ANOVA)
Decreased (< 30%)† 9% (n= 3) 42% (n= 5) 75% (n= 9)
NAA/choline ratio 1.81 ± 0.23 (n= 39) 1.87 ± 0.17 (n= 14) 1.52 ± 0.14 (n= 13) F (2, 63) = 12.3 < .001*
(ANOVA)
Decreased (< 1.59)‡ 13% (n= 5) 0% (n= 0) 54% (n= 7)
Lactate:
Absent (n) 34 10 2 X2 = 23.8 < .001
Present (n) 5 4 11 (cross-tabs)
Present (%) 13% 29% 85%
*Least significance difference tests: Group with an internal carotid artery occlusion was significantly different from the other two groups.
†Based on control data of 30 subjects (see methods section).
‡Based on control data of 19 subjects (see methods section).
ICA, Internal carotid artery; CEA, carotid endarterectomy; NAA, N-acetyl aspartate; ANOVA, analysis of variance.
Table V. Differences between groups formed on the basis of clinical symptoms on the carotid endarterec-
tomy side and percentage of patients with abnormal test values
Symptoms on CEA side Statistics
Asymptomatic Ocular TIA Minor stroke Results P value
CEA side
CO2 reactivity (%) 42 ± 25 49 ± 9 39 ± 15 30 ± 19 F (3, 54) = 1.9 NS
(n = 18) (n = 9) (n = 19) (n = 12) (ANOVA)
Decreased (< 30%)† 28% (n = 5) 0% (n = 0) 26% (n = 5) 58% (n = 7)
NAA/choline ratio 1.74 ± 0.16 1.83 ± 0.17 1.61 ± 0.19 1.51 ± 0.24 F (3, 62) = 7.3 < .001*
(n = 18) (n = 12) (n = 22) (n = 14) (ANOVA)
Decreased (< 1.59)‡ 11% (n = 2) 0% (n = 0) 46% (n = 10) 71% (n =10)
Lactate:
Absent (n) 11 8 9 3 X2 = 7.3 NS
Present (n) 7 4 13 11 (cross-tabs)
Present (%) 39% 33% 59% 79%
*Least significance difference tests: Asymptomatic and ocular symptoms groups were significantly different from the groups with tran-
sient ischemic attack or a minor stroke.
†Based on control data of 30 subjects (see methods section).
‡Based on control data of 19 subjects (see methods section).
CEA, Carotid endarterectomy; TIA, transient ischemic attack; NAA, N-acetyl aspartate; ANOVA, analysis of variance.
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with a less severe degree of contralateral stenosis. The
variance in these findings may be explained by differ-
ent collateral contributions from, for example, the
basilar system. Therefore, a contralateral ICA occlu-
sion can only be regarded as a risk factor for disordered
cerebral hemodynamics and metabolism. Additional
tests, such as the CO2 reactivity test, are required to
obtain a stratified classification of patients at risk for
cerebral ischemic complications.
The groups with cerebral symptoms (transient or
minor stroke) had a lower mean NAA/choline ratio
than the asymptomatic group (including only ocular
symptoms). Lactate was more often present in the
groups with cerebral symptoms, although differ-
ences were only statistically significant on the con-
tralateral side. The CO2 reactivity of the groups with
cerebral symptoms was also decreased only on the
contralateral side. Thus, in general, changes indica-
tive of disordered hemodynamics were found more
often in symptomatic patients than in asymptomatic
patients. This suggests that the hemodynamic effect
of an ICA stenosis contributes to the transition from
asymptomatic to symptomatic stenosis.
In conclusion, a decreased CO2 reactivity is
indicative of not only inadequate collateral blood
supply, but also of a disordered cerebral metabolism,
as indicated by the abnormal MRS findings. This is
in accordance with the finding that a decreased CO2
reactivity in patients with an ICA stenosis is a risk
factor for ischemic cerebral events.6,32,33 Our results
show that patients with a contralateral ICA occlu-
sion are especially at risk for disordered cerebral
hemodynamics and metabolism. However, not all of
these patients with severe bilateral ICA stenosis have
disordered hemodynamics, and decisions about the
indication for CEA based on clinical grounds alone
might be open to refinement. Our results support
the use of the CO2 reactivity test to identify patients
with disordered hemodynamics at one or both sides,
and this test might have the potential to refine the
indication for CEA.
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